HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Histochemical detection of expression of binding sites for labelled hyaluronic acid and carrier-immobilized synthetic (histo-blood group trisaccharides) or biochemically purified (ganglioside GM1) glycoligands in nasal polyps and other human lesions including neoplasms.

Abstract
This study is intended to demonstrate the versatility and feasibility of custom-made oligosaccharide-exposing neoglycoconjugates including histo-blood group epitopes in various human lesions, including nasal polyps. The binding of the biotinylated probes was determined on formalin-fixed paraffin-embedded sections from archive materials. The general aspects of our results may be interpreted as follows: the neoglycoconjugates used here can readily detect differences in the ability of cells to bind glycan residues in tissue sections, thereby enabling the extent of the binding capacity of various types of human lesions to be compared. Furthermore, the reactivity to glycan may reflect characteristics of the cells and their environment. The investigation into pathological disorders with respect to the binding capacity of these carrier-immobilized mono- or oligosaccharide structures derived from custom-made synthesis or biochemical purification is based on the prospect of translating progress in this field into the establishment of potentially beneficial procedures for medical diagnosis and pathological classification.
AuthorsS Hassid, I Salmon, N V Bovin, R Kiss, H J Gabius, A Danguy
JournalHistology and histopathology (Histol Histopathol) Vol. 11 Issue 4 Pg. 985-92 (Oct 1996) ISSN: 0213-3911 [Print] Spain
PMID8930641 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Blood Group Antigens
  • Glycoconjugates
  • Trisaccharides
  • G(M1) Ganglioside
  • Hyaluronic Acid
Topics
  • Adenocarcinoma (pathology)
  • Binding Sites
  • Blood Group Antigens (analysis, chemistry)
  • Brain Neoplasms (pathology)
  • Breast Neoplasms (pathology)
  • Carcinoma, Ductal, Breast (pathology)
  • Carcinoma, Transitional Cell (pathology)
  • Colonic Neoplasms (pathology)
  • Feasibility Studies
  • Female
  • Fibroadenoma (pathology)
  • G(M1) Ganglioside
  • Glioblastoma (pathology)
  • Glycoconjugates (analysis)
  • Histocytochemistry
  • Humans
  • Hyaluronic Acid
  • Male
  • Melanoma (pathology)
  • Nasal Polyps (pathology)
  • Neoplasms (pathology)
  • Prostatic Hyperplasia (pathology)
  • Skin Neoplasms (pathology)
  • Trisaccharides
  • Urinary Bladder Neoplasms (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: